140 related articles for article (PubMed ID: 6260045)
1. A coded study of antitumor immunity to human lung cancer assayed by tube leukocyte adherence inhibition.
Thomson DM; Ayeni RO; MacFarlane JK; Tataryn DN; Terrin M; Schraufnagel D; Wilson J; Mulder DS
Ann Thorac Surg; 1981 Apr; 31(4):314-21. PubMed ID: 6260045
[TBL] [Abstract][Full Text] [Related]
2. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
3. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
4. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
5. Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.
Gubersky M; Thomson DM; Lajzerowicz M
Cancer Immunol Immunother; 1986; 21(2):107-13. PubMed ID: 3633212
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
7. A computerized tube leukocyte adherence inhibition assay in the diagnosis of human lung cancer.
Fink A; Eliraz A; Bruderman I; Wishnitzer R; Shindler D; Shani A; Offer S; Harpaz N; Bentwich Z
Diagn Immunol; 1985; 3(4):171-6. PubMed ID: 2417775
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
9. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
10. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
11. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte adherence inhibition test in lung cancer immunodiagnostic detection.
Lodi M; Cavallini G; Pampolini M
Ital J Surg Sci; 1988; 18(1):25-34. PubMed ID: 2836338
[TBL] [Abstract][Full Text] [Related]
13. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
15. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
[TBL] [Abstract][Full Text] [Related]
17. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte adherence inhibition assay in human pulmonary neoplasia.
Kotlar HK; Eker P; Brennhovd I; Høst H; Høie J; Sanner T
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):141-6. PubMed ID: 7047165
[TBL] [Abstract][Full Text] [Related]
19. The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
Lopez M; O'Connor R; MacFarlane JK; Thomson DM
Br J Cancer; 1978 Dec; 38(6):660-73. PubMed ID: 369585
[TBL] [Abstract][Full Text] [Related]
20. The humoral leukocyte adherence inhibition in the discrimination among histologic types of lung cancer.
Horváth M; Fekete B; Forrai I
Oncology; 1983; 40(5):326-31. PubMed ID: 6194487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
